Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study.

被引：0
|
作者：
Giannessi, PG [1 ]
Martella, F [1 ]
Di Marsico, R [1 ]
Coltelli, L [1 ]
Safina, V [1 ]
Andreuccetti, M [1 ]
Falcone, A [1 ]
机构：
[1] UO Oncol Med, Livorno, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [1] CAPECITABINE AND GEMCITABINE IN METASTATIC BREAST CANCER: A PHASE I-II STUDY
    Giannessi, P. G.
    Di Marsico, R.
    Martella, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [2] Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer
    Pusztai, L
    Zhen, JH
    Arun, B
    Rivera, E
    Whitehead, C
    Thompson, WJ
    Nealy, KM
    Gibbs, A
    Symmans, WF
    Esteva, FJ
    Booser, D
    Murray, JL
    Valero, V
    Smith, TL
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) : 3454 - 3461
  • [3] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: phase II study.
    Tanaka, M.
    Tamura, K.
    Anan, K.
    Ohno, S.
    Nishimura, R.
    Yamamoto, Y.
    Masuda, N.
    Mitsuyama, S.
    CANCER RESEARCH, 2009, 69 (02) : 383S - 384S
  • [4] Combination of docetaxel and mitoxantrone for the therapy of metastatic breast cancer - a phase I-II study
    von Minckwitz, G
    Costa, SD
    Loibl, S
    Caminada, MC
    Kaufmann, M
    TUMORDIAGNOSTIK & THERAPIE, 1998, 19 (05) : 149 - 154
  • [5] Gemcitabine and capecitabine in metastatic breast cancer (MBC): A Brown University Oncology Group (BrUOG) phase II study.
    Sikov, WM
    Theall, KP
    Seidler, CW
    Strenger, RS
    Fenton, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 74S - 74S
  • [6] Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study
    Stier, S
    Koll, C
    Neuhaus, T
    Fronhoffs, S
    Forkert, R
    Tuohimaa, A
    Vetter, H
    Ko, Y
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1115 - 1121
  • [7] Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study.
    Adamo, V
    Ferrandina, G
    Spada, M
    Ferrau, F
    Condemi, G
    Di Lullo, L
    Lorusso, D
    Rossello, R
    Garipoli, C
    Scambia, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 75S - 75S
  • [8] Phase I study of imatinib in combination with gemcitabine and capecitabine
    Ramaekers, R. C.
    Elkahwaji, J.
    Reed, E.
    Ganti, A.
    Wang, J.
    Grem, J.
    Baranowska-Kortylewicz, J.
    Hauke, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Phase I-II study of oral vinorelbine (NVBO) and capecitabine (X) in metastatic breast cancer (MBC): Results of the phase I trial
    Anton, A.
    Lluch, A.
    Casado, A.
    Provencio, M.
    Munoz, M.
    Lao, J.
    Bermejo, B.
    Paules, A. B.
    Gayo, J.
    Martin, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Phase I-II study to evaluate safety and efficacy of capecitabine (Xeloda) and exisulind (Aptosyn) combination therapy in patients with metastatic breast cancer.
    Pusztai, L
    Nealy, KM
    Pallansch, P
    Rivera, E
    Valero, V
    Cristofanilli, M
    Hortobagyi, GN
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 285 - 285
12345